Pulmonary Drug Delivery Technologies

Pulmonary Drug Delivery Technologies
  • Report price : $ 3 850
  • Publication date : June 2007
  • Length : 332 pages

Get this Report Now !

Pulmonary Drug Delivery Technologies

This report analyzes the worldwide markets for Pulmonary Drug Delivery Technologies in Millions of US$. The specific product segments analyzed are Metered Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs) and Nebulizers. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual forecasts are provided for each region and product segment for the period of 2000 through 2010. The report profiles 55 companies including many key and niche players worldwide such as 3M Pharmaceuticals, 3M Drug Delivery Systems Division, Alkermes Inc., Aradigm, AstraZeneca Plc, Baxter Healthcare Corporation, Bespak Europe Ltd, Chiesi Farmaceutici SpA, Dey L.P., GlaxoSmithKline, Inyx Inc., LAB International Inc., Nektar Therapeutics, Oriel Therapeutics Inc., Sepracor Inc., SkyePharma Plc, Vectura, and Ventaira Pharmaceuticals Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

RELATED REPORTS

Canadian Pharmaceutical Sector: Industry Profile

Canadian Pharmaceutical Sector: Industry Profile

  • $ 600
  • June 2008
  • 25 pages

This industry profile helps to gain an insight into the evolution of the industry and competitive dynamics prevalent in the market. It discusses the significant developments in the industry and analyzes the key trends and issues. The profile provides inputs in strategic business planning of industry ...

Industries : Pharmaceutical | Countries : Canada, USA

Canadian Drug Sector: Industry Profile

Canadian Drug Sector: Industry Profile

  • $ 600
  • June 2008
  • 25 pages

This industry profile helps to gain an insight into the evolution of the industry and competitive dynamics prevalent in the market. It discusses the significant developments in the industry and analyzes the key trends and issues. The profile provides inputs in strategic business planning of industry ...

Industries : Pharmaceutical | Countries : Canada, USA

Generic Series: An Introduction to the Canadian Generics Market - Key trends and leading companies shaping the market

Generic Series: An Introduction to the Canadian Generics Market - Key trends and leading companies shaping the market

  • $ 3 800
  • June 2007
  • 47 pages

IntroductionThe Canadian pharmaceutical market is the 8th largest globally and as such represents an important market for generics manufacturers. Although historically dominated by domestic generics companies, mergers and acquisitions over the last five years have increased the dominance of foreign ...

Industries : Pharmaceutical | Countries : Canada, USA

Barrier Therapeutics, Inc. - SWOT Analysis

Barrier Therapeutics, Inc. - SWOT Analysis

  • $ 125
  • July 2007
  • 20 pages

Datamonitor's Barrier Therapeutics, Inc. - SWOT Analysis Company Profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and st ...

Industries : Pharmaceutical | Countries : Canada, USA, Belgium

Global Smoking Cessation Market Analysis & Forecasts - Preparing for the first blockbuster

Global Smoking Cessation Market Analysis & Forecasts - Preparing for the first blockbuster

  • $ 3 358
  • July 2007
  • 151 pages

Cigarette smoking is the most important source of preventable and premature morbidity worldwide. Currently, the number of smokers across the globe is estimated at 1.3 billion. Political moves are leading to national bans of smoking in public places, with the long-term aim to reduce the cost to the h ...

Industries : Pharmaceutical | Countries : Canada, USA, Japan, Sweden, Germany, Spain, France, Italy, United Kingdom, Australia

Parallel Trade - US Lawmakers allow imported prescriptions drugs

Parallel Trade - US Lawmakers allow imported prescriptions drugs

  • $ 3 358
  • June 2007
  • 143 pages

``Parallel Trade acts as an important driving force for market integration where there are important differences in price between member states``- European Commission Communication on the single market in pharmaceuticalsParallel trade is on the verge of breaking its confines of the EU and diffusing ...

Industries : Pharmaceutical | Countries : Mexico, Canada, USA, Cyprus, Denmark, Norway, Sweden, Germany, United Kingdom

Cannabinoid Market Forecasts & Analysis to 2012

Cannabinoid Market Forecasts & Analysis to 2012

  • $ 3 358
  • March 2007
  • 199 pages

With 4 drugs now in the marketplace (a 100% rise from 2 years ago), the cannabinoid market continues to grow. Attitudes to the drugs are changing ensuring greater market penetration, and the first cannabinoid blockbuster is now a certainty.4 drugs already available: * Marinol® (dronabinol) * ...

Industries : Pharmaceutical | Countries : Canada, USA, Germany, Spain, France, Italy, United Kingdom

Tissue Engineering & Stem Cell Technology Report 2007

Tissue Engineering & Stem Cell Technology Report 2007

  • $ 2 219
  • February 2007
  • 171 pages

Over 160+ pages dedicated to tissue engineering and stem cell analysis.The market potential of this technology is so huge that revenues may be in excess of $10 billion by 2013. This is a market that you should be part of - NOW!! With a complex regulatory structure still to overcome, yet continued h ...

Industries : Biotechnology, Pharmaceutical, Pathology | Countries : Canada, USA, United Kingdom

reportlinker.com © Copyright 2009. All rights reserved

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.